MSCs can reduce the expression of CCL1, CCL3, CCL8, CCL17, CCL22, and CCR4 on Th2, Th17, as well as Th22 cells, CCR8 on Th2 cells, and CCR1 on CD11β+ macrophages in autoimmune-related fibrotic skin to hinder the arrival of CD4+ T cells, including Th17 and Th2 cells, and CD11β+ macrophages, in particular [13, 40, 41]. The gene discussed is ITGAM; the disease is neoplasm.